Achieve Life Sciences
ACHV
48 hedge funds and large institutions have $18.2M invested in Achieve Life Sciences in 2015 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 9 closing their positions.
122% more call options, than puts
Call options by funds: $71K | Put options by funds: $32K
8% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 13
1% less capital invested
Capital invested by funds: $18.4M → $18.2M (-$259K)
2% less funds holding
Funds holding: 49 → 48 (-1)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
Top Sellers
ACHV Hedge Fund Activity: Q2 2015 in Review
48 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2015, worth a combined $18.2M — down 1.4% from $18.4M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ACHV and 8 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 14 added.
The largest buyer was Renaissance Technologies, adding an estimated $461K. The largest seller was Tang Capital Management, exiting entirely with an estimated $1.35M sold.
- 48 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2015, down from 49 in Q1 2015.
- Funds reported $18.2M of Achieve Life Sciences stock for Q2 2015, down 1.4% quarter-over-quarter.
- 8 funds opened new Achieve Life Sciences positions in Q2 2015 and 9 closed out, a net change of -1 holder.
- The largest Achieve Life Sciences buyer in Q2 2015 was Renaissance Technologies, an estimated $461K added.
- The largest Achieve Life Sciences seller in Q2 2015 was Tang Capital Management, an estimated $1.35M sold.
Based on aggregated 13F filings for Q2 2015.